Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C9H18O11P.C5H14NO |
| Molecular Weight | 437.3771 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CCO.OC[C@@H](O)COP([O-])(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
InChI
InChIKey=PTZZCYHESHNXFL-RCEFGWESSA-M
InChI=1S/C9H19O11P.C5H14NO/c10-1-3(11)2-19-21(17,18)20-9-7(15)5(13)4(12)6(14)8(9)16;1-6(2,3)4-5-7/h3-16H,1-2H2,(H,17,18);7H,4-5H2,1-3H3/q;+1/p-1/t3-,4-,5-,6+,7-,8-,9-;/m1./s1
Glycerophosphoinositol choline is a salt of glycerophosphoinositol and choline. It is used in cream or emollient formulation in the treatment of irritative and allergic dermatitis and xerosis of the skin. Glycerophosphoinositol is a natural metabolite, produced in the organism through deacylation by phospholipase B of the essential phospholipid phosphatidylinositol. Glycerophosphoinositols are involved in control of signalling enzymes (e.g. adenylyl cyclase), in actin cytoskeleton organization, in invasion of the extracellular matrix by melanoma and breast carcinoma cell lines, and in the control of cell proliferation in epithelial cells.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2123309
Created by
admin on Sat Dec 16 11:06:55 UTC 2023 , Edited by admin on Sat Dec 16 11:06:55 UTC 2023
|
PRIMARY | |||
|
425642-32-6
Created by
admin on Sat Dec 16 11:06:55 UTC 2023 , Edited by admin on Sat Dec 16 11:06:55 UTC 2023
|
PRIMARY | |||
|
3W4V4N5240
Created by
admin on Sat Dec 16 11:06:55 UTC 2023 , Edited by admin on Sat Dec 16 11:06:55 UTC 2023
|
PRIMARY | |||
|
3W4V4N5240
Created by
admin on Sat Dec 16 11:06:55 UTC 2023 , Edited by admin on Sat Dec 16 11:06:55 UTC 2023
|
PRIMARY |
SUBSTANCE RECORD
